7invensun

Beijing 7invensun Technology Co., Ltd. is a high-tech enterprise dedicated to the fields of machine vision and artificial intelligence, with fully independent intellectual property rights. Since its establishment, the company has focused on the research, development, and innovation of eye-tracking technology, aiming to upgrade and optimize the human-computer interaction experience for all terminal devices.Over the past 11 years, 7invensun has helped tens of thousands of people with ALS, patients who have lost the ability to communicate, and individuals with disabilities regain their communication abilities through its eye-controlled communication aids by enabling typing with their eyes.From 2014 to 2016, 7invensun received venture capital investment from Qualcomm, the American mobile chip giant, for three consecutive years.In 2016, 7invensun released the VR eye-tracking module aGlass, which was the first to achieve three "cutting-edge technologies": foveated rendering, eye-controlled interaction, and eye movement data analysis.From 2018 to 2019, 7invensun successfully developed the aSee AR module and the aSee Glasses eye tracker, and established a strategic partnership with the Center for Innovation in Vision and Optics (CIVO) at the University of California, Berkeley.The corporate vision of 7invensun is to become one of China's most outstanding original technology companies, leading the continuous development of the cutting-edge eye-tracking technology and applying it broadly in areas such as smart healthcare, VR/AR, smartphones, advertising media, intelligent vehicles, robotics, aerospace, and more.